350 related articles for article (PubMed ID: 38397480)
1. The Role of the Dysregulated JNK Signaling Pathway in the Pathogenesis of Human Diseases and Its Potential Therapeutic Strategies: A Comprehensive Review.
Yan H; He L; Lv D; Yang J; Yuan Z
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397480
[TBL] [Abstract][Full Text] [Related]
2. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
3. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.
Guicheux J; Lemonnier J; Ghayor C; Suzuki A; Palmer G; Caverzasio J
J Bone Miner Res; 2003 Nov; 18(11):2060-8. PubMed ID: 14606520
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation.
Yen A; Roberson MS; Varvayanis S
In Vitro Cell Dev Biol Anim; 1999 Oct; 35(9):527-32. PubMed ID: 10548434
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors.
Shen YH; Godlewski J; Zhu J; Sathyanarayana P; Leaner V; Birrer MJ; Rana A; Tzivion G
J Biol Chem; 2003 Jul; 278(29):26715-21. PubMed ID: 12738796
[TBL] [Abstract][Full Text] [Related]
6. JNK/SAPK Signaling Is Essential for Efficient Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.
Neganova I; Shmeleva E; Munkley J; Chichagova V; Anyfantis G; Anderson R; Passos J; Elliott DJ; Armstrong L; Lako M
Stem Cells; 2016 May; 34(5):1198-212. PubMed ID: 26867034
[TBL] [Abstract][Full Text] [Related]
7. Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma.
Kunz M; Ibrahim S; Koczan D; Thiesen HJ; Köhler HJ; Acker T; Plate KH; Ludwig S; Rapp UR; Bröcker EB; van Muijen GN; Flory E; Gross G
Cell Growth Differ; 2001 Mar; 12(3):137-45. PubMed ID: 11306514
[TBL] [Abstract][Full Text] [Related]
8. [MAPK signaling pathway and erectile dysfunction].
Chen SX; Zhao F; Huang XJ
Zhonghua Nan Ke Xue; 2018 May; 24(5):442-446. PubMed ID: 30171761
[TBL] [Abstract][Full Text] [Related]
9. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
[TBL] [Abstract][Full Text] [Related]
10. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
11. JNK and p38 mitogen-activated protein kinase pathways contribute to porcine epidemic diarrhea virus infection.
Lee C; Kim Y; Jeon JH
Virus Res; 2016 Aug; 222():1-12. PubMed ID: 27215486
[TBL] [Abstract][Full Text] [Related]
12. Mixed lineage kinase LZK forms a functional signaling complex with JIP-1, a scaffold protein of the c-Jun NH(2)-terminal kinase pathway.
Ikeda A; Hasegawa K; Masaki M; Moriguchi T; Nishida E; Kozutsumi Y; Oka S; Kawasaki T
J Biochem; 2001 Dec; 130(6):773-81. PubMed ID: 11726277
[TBL] [Abstract][Full Text] [Related]
13. PP2A regulates upstream members of the c-jun N-terminal kinase mitogen-activated protein kinase signaling pathway.
Zhao B; Sun L; Haas M; Denenberg AG; Wong HR; Shanley TP
Shock; 2008 Feb; 29(2):181-8. PubMed ID: 17693927
[TBL] [Abstract][Full Text] [Related]
14. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.
Schett G; Tohidast-Akrad M; Smolen JS; Schmid BJ; Steiner CW; Bitzan P; Zenz P; Redlich K; Xu Q; Steiner G
Arthritis Rheum; 2000 Nov; 43(11):2501-12. PubMed ID: 11083274
[TBL] [Abstract][Full Text] [Related]
15. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
16. Metastasis and MAPK Pathways.
Kciuk M; Gielecińska A; Budzinska A; Mojzych M; Kontek R
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409206
[TBL] [Abstract][Full Text] [Related]
17. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
[TBL] [Abstract][Full Text] [Related]
18. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
Ito M; Yoshioka K; Akechi M; Yamashita S; Takamatsu N; Sugiyama K; Hibi M; Nakabeppu Y; Shiba T; Yamamoto KI
Mol Cell Biol; 1999 Nov; 19(11):7539-48. PubMed ID: 10523642
[TBL] [Abstract][Full Text] [Related]
19. Acrolein activates mitogen-activated protein kinase signal transduction pathways in rat vascular smooth muscle cells.
Ranganna K; Yousefipour Z; Nasif R; Yatsu FM; Milton SG; Hayes BE
Mol Cell Biochem; 2002 Nov; 240(1-2):83-98. PubMed ID: 12487375
[TBL] [Abstract][Full Text] [Related]
20. JNK pathway: diseases and therapeutic potential.
Cui J; Zhang M; Zhang YQ; Xu ZH
Acta Pharmacol Sin; 2007 May; 28(5):601-8. PubMed ID: 17439715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
